je.st
news
Merck Marks 30-Year Milestone in Commitment to Innovation and Care in HIV/AIDS
2015-07-21 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Unveils Positively Committed Campaign at International AIDS Society Conference KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the company's commitment to HIV and AIDS, which started with a research and development program initiated in the mid-1980s during the early years of the epidemic, is now entering its fourth decade. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558orCarmen de Gourville, 267-305-4195orInvestor:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: in
care
commitment
marks
Category:Biotechnology and Pharmaceuticals